This year's federal budget has elicited a wide range of both praise and criticism. Below are highlights taken from statements issued by Canada's research and education communities:

Russell Williams, President, Canada's Research-based Pharmaceutical Companies (Rx&D)

"We are concerned that proposed changes to the Scientific Research and Experimental Development (SR&ED) tax credit could be detrimental to life science research and development in Canada.